Rochester, New York (PRWEB) February 04, 2012

Gardasil is the FDA approved HPV vaccine. As of September 15, 2011, the Centers for Disease Control (CDC) received a total of 20,096 reports of adverse events in relation to Gardasil vaccination. Dr. Hanan Polansky, Director of the Center for the Biology of Chronic Disease, will discuss his discovery of Microcompetition with Norma Erickson, President of SANE Vax Inc. Dr. Polansky will use Microcompetition to explain the biological mechanism underlying the Gardasil adverse events. Leslie Carol Botha will host the event on the Holy Hormones Radio Show. The show will be broadcast on the community radio station KRFC FM in Fort Collins, CO, Monday, February 6, from 6 to 7pm MST.

Dr. Hanan Polansky is the author of the highly acclaimed “Purple” book, entitled Microcompetition with Foreign DNA and the Origin of Chronic Disease. In his book he explains how foreign DNA fragments can cause many major diseases without damaging (mutating) the human DNA. The book has been read by more than 5,000 scientists around the world, and has been reviewed in more than 20 leading scientific journals.

“Even if only a portion of the author’s (Dr. Hanan Polansky’s) thesis is correct, it would establish wholly new insights into the pathogenesis of chronic disease states, and would have significant implications for treatment and/or prevention.” – Kim E. Barrett, PhD – Professor of Medicine and Vice-Chair for Research, Department of Medicine, University of California, San Diego, School of Medicine

The FDA says on its website that “Since the early development of Gardasil, FDA and the manufacturer (Merck and Co., Inc.) have known that after purification of the vaccine, small quantities of residual recombinant HPV L1-specific DNA fragments remain in the vaccine.” … “The presence of DNA fragments is expected in Gardasil … these are not contaminants …. The presence of these DNA fragments is expected, is not a risk to vaccine recipients, and is not a safety factor.”

The FDA and Merck admit that Gardasil contains foreign DNA fragments. However, the FDA asserts that these foreign DNA fragments pose no risk. In contrast, Dr. Hanan Polansky, in his highly acclaimed “Purple” book explains how certain foreign DNA fragments, at high concentrations, cause major diseases, such as, cancer, heart disease, diabetes, autoimmune diseases, and even obesity even when the DNA is broken and not functioning.

In fact, the center encourages biologists, virologists, geneticists and scientists and the general public to obtain a copy of Dr. Hanan Polansky’s book and read it before the radio interview on February 6th. The book is available as a free download from the CBCD website.

(http://www.cbcd.net)

“Dr. Polansky takes an interesting approach when relating the diseases discussed in this book. He uses a detailed quantitative analysis to explain his theories of microcompetition with foreign DNA. I especially enjoyed how he found links between these different chronic diseases. It was quite thought-provoking.” – Afshin Beheshti, PhD Research Associate, Department of Molecular Genetics, The Forsyth Institute, (Harvard Medical Center Affiliate)

The CBCD endorses Dr. Polansky’s theory, and invites the media, scientists, and the general public to contact us on this issue.

For more information on the Center for the Biology of Chronic Disease, or to schedule an interview with Dr. Polansky, please visit http://www.cbcd.net or call 585-250-9999.

The FDA quotes above can be found here:

http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm276859.htm

The Center for the Biology of Chronic Disease (CBCD, http://www.cbcd.net) is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments for these diseases.

The CBCD published the “Purple” book entitled “Microcompetition with Foreign DNA and the Origin of Chronic Disease” written by Dr. Hanan Polansky. The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between the DNA of latent (chronic) viruses and the onset of chronic diseases. Dr. Polansky’s book is available as a free download from the CBCD website.

We invite biologists, virologists, and scientists everywhere to download Dr. Polansky’s book here: http://cbcd.net/.

# # #

Attachments

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Ramsey, NJ (PRWEB) February 21, 2012

Konica Minolta Business Solutions U.S.A., Inc. (Konica Minolta) today announced its participation in the 2012 Annual HIMSS Conference & Exhibition, Februrary 21 – 23 at the Venetian Sands Expo Center in Las Vegas. Highlighting the EnvisionIT Healthcare solutions and services designed to help healthcare facilities reduce costs and maximize operational efficiencies, Konica Minolta will also be showcasing professional services, hardware and new integrated solutions uniquely designed to support healthcare facilities of all sizes.

At HIMSS 2012, Konica Minolta will be exhibiting the following in Booth #8903:

    IT Services for Healthcare – Konica Minolta offers IT Services through its All Covered division, providing healthcare facilities cost effective solutions for IT and networking services. Services range from IT management, email security, server and network monitoring and 24×7 client help desk support designed to support healthcare specific IT requirements
    Managed Print Services for Healthcare – Konica Minolta’s Optimized Print Services program drives print cost reduction through a consultative process starting with a site assessment. Recommendations are delivered in the area of print management design, implementation, workflow improvements coupled with enterprise cost saving opportunities to meet the needs of any size practice, clinic or hospital.
    NSi AutoStore™ for Medical Documents – Available on Konica Minolta’s award winning line of bizhub® Multifunctional Products (MFPs – print, copy, fax, and scan all in one system), NSi AutoStore for medical documents provides healthcare administrators the ability to press a single button on the control panel of a bizhub MFP and automatically scan prescriptions to pharmacies or directly to electronic medical record applications. This advanced capability results in the reduction of transmission errors, lowers costs, and assists healthcare facilities in providing more timely and efficient services to patients.
    NSi AutoStore for US Veterans Affairs and Department of Defense (DoD) Healthcare Organizations – The DoD currently utilizes NSi AutoStore to support enterprise capture capabilities for its Healthcare Artifact and Image Management Solution (HAIMS) project. NSi AutoStore is integrated directly into the control panel of bizhub MFPs enabling medical professionals to securely capture documents or medical images and route them to an Electronic Healthcare Records (EHRs) system from the MFP. As a result, military healthcare providers have access to data throughout the individual’s history of care.
    Konica Minolta’s Body Area Network (BAN) – An increasing number of healthcare facilities currently require scanning smart cards to validate employees’ in-house entry, exit or use of PCs and MFPs for enhanced security management. Konica Minolta and Ad-Sol Nissin have collaborated in overcoming authentication challenges by utilizing BAN technologies to develop a system where nothing more is required other than the human body’s touch on the device or its accessory to complete identity verification to operate the MFP.
    bizhub C754 Series – Ideal for physician practices and healthcare facilities of all sizes, the bizhub C754 was designed to print, copy, scan and fax faster than most other color multifunction printers. It offers standard dual scanning, an innovative INFO-Palette design and achieves among the lowest power consumption rates in its class.
    Konica Minolta Medical Imaging (KMMI) ImagePilot Integration with bizhub MFPs – Technology Preview – A fully integrated imaging workflow between scanned patient records and digital radiography imaging equipment is offered from Konica Minolta Medical Imaging. Scanned documents from a bizhub MFP can be sent directly to ImagePilot, KMMI’s flagship desktop radiography system, and subsequently tagged with all of a patient’s records.
    eCopy ShareScan V5 – Embedded directly on Konica Minolta bizhub multifunctional products (MFP), eCopy ShareScan software allows for a wide range of secure document scanning processes with seamless integration into business applications that support automated workflows helping healthcare professionals and facilities reduce the costs of document management, and comply with HIPAA security requirements for PHI. eCopy offers HL7 Clinical Document Architecture (CDA) Based Exchange between Konica Minolta bizhub MFPs and leading Electronic Health Record (EHR) Systems.
    Prism Healthflow- Automating healthcare document management substantially reduces costs and improves efficiencies. HealthFlow eliminates paper use and dependency in three key areas of the healthcare facility: forms, manual workflow processes, and the storage and archiving of completed forms, documents and other records. This healthcare document management system was made to streamline workflow and keep documents secure.
    My PrintManager – Part of PageScope Enterprise Suite, My PrintManager allows for Secure Print Release from any networked bizhub MFP device. This allows users throughout a Healthcare facility to conveniently meet HIPAA PHI Requirements related to the confidentiality of healthcare document printing
    PageScope Mobile – A secure mobile printing app that connects the award-winning line of bizhub MFPs via a wireless LAN connection with the suite of Apple products.

“Konica Minolta’s healthcare-focused products, solutions and services which comprise the EnvisionIT Healthcare suite, aim to help medical practices work smarter with integrated workflow solutions that streamline current healthcare work processes,” said Sam Errigo, Senior Vice President, Business Intelligence Services, Konica Minolta Business Solutions U.S.A., Inc. “As a global leader in offering award-winning HIPAA compliance, digital document and scanning solutions, and Electronic Health Records, Konica Minolta ensures that healthcare customers can count on us for the solutions that keep their businesses productive and efficient.”

About Konica Minolta

Konica Minolta Business Solutions U.S.A., Inc. is a leader in advanced document management technologies and Managed IT Services for the desktop to the print shop. For the fifth consecutive year, Konica Minolta was recognized as the #1 Brand for Customer Loyalty in the MFP Office Copier Market by Brand Keys. BLI has named Konica Minolta 2012 “Document Imaging Solutions Line of the Year” and “A3 MFP Line of the Year” award winner for the company’s solution portfolio and award-winning line of bizhub Multifunctional Products. For more information, please visit http://www.CountOnKonicaMinolta.com and follow Konica Minolta on Facebook, YouTube, and Twitter.

Konica Minolta Contact

Rachel Reed

Konica Minolta Business Solutions U.S.A., Inc.

+1 856.381.0651

rachel.reed(at)kmbs(dot)konicaminolta(dot)us

Konica Minolta is a trademark of Konica Minolta Holdings, Inc. bizhub is a registered trademark of Konica Minolta Business Technologies, Inc. All other trademarks mentioned in this document are the property of their respective owners.

###

Attachments

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Newport Beach, Calif. (Vocus) September 20, 2007

As part of its long-term commitment to the growth and development of specialized, patient-centered care programs and services, Hoag Hospital named Dr. Michael Krychman, one of the world’s leading experts in sexual health and survivorship medicine, the medical director of its new Sexual Health and Survivorship Medicine program.

Known both nationally and internationally for his research and work in the field of female sexual health and cancer survivorship, Dr. Krychman co-founded The Sexual Medicine and Rehabilitation Program at Memorial Sloan-Kettering Cancer Center in New York City. He is a board-certified OB/GYN and a licensed clinical sexologist, with a master’s degree in public health and human sexuality.

Dr. Krychman’s expertise reaches beyond geographical borders to include research and writing for various medical journals, including co-authoring chapters for “Cancer, Sexuality and Sexual Expression” in Female Dysfunction, 1st edition. He has also served on a variety of editorial review and advisory boards overseeing a diverse range of topics related to gynecologic oncology, sexual health, female dysfunction and survivorship medicine. He recently published “100 Questions & Answers for Women Living with Cancer: A Practical Guide to Female Cancer Survivorship.”

A Shift In Women’s Health Care

“The term ‘sexual dysfunction’ has gained notoriety due to popular male-enhancing, performance drugs such as Viagra,” said Vivian Dickerson, M.D., FACOG, and Hoag’s Medical Director of Women’s Health Programs & Care. “However, what is not recognized, nor fully supported by the mainstream medical community is the phenomenon of female sexual dysfunction and the impact it has on a woman’s health, intimate relationships and general well-being.”

According to Dickerson, the importance of sexual health, and the medical and relationship issues that result in sexual dysfunction are being taken a little more seriously within the women’s health care industry. However, “it is still a long way from being recognized as a ‘subspecialty’ or even considered a valid medical condition.”

“Women’s sexual concerns are also often ignored or treated as psychological, social or emotional complaints by their health care providers. Hoag’s program takes full advantage of Dr. Krychman’s clinical expertise in sexual health and survivorship medicine to treat the complex layers of a woman’s sexuality as well as provide follow-up care for chronic and long-term dysfunction,” stated Dickerson.

Sexual Health and Survivorship Medicine

Hoag Hospital’s Sexual Health and Survivorship Medicine program incorporates two, highly specialized areas of focus for women of all ages and sexual orientation. These include:

Sexual Health, which focuses on enhancing sexual health and intimacy for women with disorders of sexual function as a result of pain, illness, hormonal changes, medications, stress and cancer and its treatments.

And, Survivorship Medicine, which focuses on long-term, quality-of-life concerns and sexual health issues for women living with a chronic medical illness, a history of cancer or those who are at risk for developing cancer.

Sexual Health

Sexual dysfunction affects nearly half of all post-pubertal women in the U.S. as well as the vast majority of peri- and post-menopausal women. Women often experience symptoms that can greatly reduce their desire for intimacy as well as impair their quality of life. For instance, such chronic illnesses as hypertension, cardiovascular disease, diabetes and neurological disorders may impact a woman’s sexual function.

Additionally, many drug classes used to treat these conditions can affect the sexual response cycle and cause sexual dysfunction. Hormones also play a significant role in regulating sexual function. Loss of estrogen and androgen affects both the central nervous system and the sensory organs that determine the quality of sexual response, therefore, peri- and post-menopausal women often experience sexual problems, especially dysparenia and vaginal atrophy.

Sexual dysfunction is also a common consequence of cancer therapy that may persist after treatment is completed. It is reported that 90% of female cancer survivors have some form of long-lasting sexual complaint. Chemotherapy and radiation (especially to the pelvic area) can result in a sudden loss of estrogen production in the ovaries causing a woman to experience symptoms of menopause including vaginal dryness, vaginal atrophy and dysparenia. Hormonal manipulation, specifically anti-estrogens and aromatase inhibitors, can also exacerbate menopausal symptoms.

Moreover, women undergoing a radical hysterectomy, cystectomy, abdominal-perineal resection and vulvectomy to remove cancer in the reproductive organs will also experience menopause and the symptoms previously discussed. These operative procedures can also change the structural anatomy and compromise the neurovascular integrity to organ systems that are critical to sexual responsiveness.

Survivorship Medicine

In addition to treating female sexual dysfunction, Hoag’s Sexual Health and Survivorship Medicine program also delivers specialized care to women living with chronic medical illnesses, such as Multiple Sclerosis, heart disease, diabetes and many others, as well as to women who may have been recently diagnosed with any type of cancer; women who have received chemotherapy, surgery or radiation; or, women, who may be preparing to undergo these types of cancer-related procedures. The program is designed to restore a woman’s sexual health and function, optimize levels of intimacy, improve overall health and well being, and, help reduce risks for cancer reoccurrence.

About Dr. Krychman

Prior to serving as Co-Founder and -Director of Sexual Medicine at Memorial Sloan-Kettering Cancer Center, Dr. Krychman held positions as Associate Professor at Cornell Medical School in New York City, and before that was on staff at Temple University Hospital and Episcopal Hospital in Philadelphia.

Dr. Krychman holds licenses from three states including California, Pennsylvania and New York. His clinical interests are diverse, ranging from chemotherapy-induced chemical dysparenia to management of sexual dysfunction in cancer and non-cancer patients. His special interests include sexual pain disorders, loss of libido, chronic medical illness and its impact on female sexual function, as well as breast cancer sexuality.

Fluent in French and English, Dr. Krychman obtained his doctorate in medicine and masters in surgery from McGill University School of Medicine in Montreal, where he was named a “Great Distinction Medical Scholar.”

About Hoag Memorial Hospital Presbyterian

Hoag Memorial Hospital Presbyterian (http://www.hoaghospital.org) is a 498-bed, not-for-profit, acute care hospital located in Newport Beach, Calif. Fully accredited by the Joint Commission on Accreditation of Healthcare Organizations and designated as a Magnet hospital by the American Nurses Credentialing Center (ANCC), Hoag offers a comprehensive mix of health care services, including Centers of Excellence in cancer, heart and vascular, neurosciences, orthopedics and women’s health. Recent studies released by HealthGrades place Hoag among the top 5% of hospitals in the nation for both Clinical Excellence and Patient Safety. National Research Corporation has endorsed Hoag as Orange County’s most preferred hospital for the past 10 consecutive years. And for an unprecedented 11 years, residents of Orange County have chosen Hoag as the county’s best hospital in a local newspaper survey.

# # #

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

(PRWEB) February 20, 2012

The February issue of Inside Health Insurance Exchanges, a new newsletter from AIS, includes the first in-depth interview with Joel Ario, who recently left his post as director of HHS’s Office of Health Insurance Exchanges, a department that he headed after it was created in fall 2010.

In the exclusive interview, Ario offers his perspective on the hurdles and opportunities exchanges will create for health plans and states, as well as his thoughts on how a system of state-based exchanges will alter the health insurance landscape.

“Health care, like other consumer products, can be boiled down and made consumer friendly and we can create competition like we do in other complicated products,” Ario tells Inside Health Insurance Exchanges. He also provides his thoughts on the progress states have made in developing exchanges, what insurers will to do to effectively compete in them, and whether public and private exchanges can co-exist.

Go to http://aishealth.com/marketplace/inside-health-insurance-exchanges to read the interview in its entirety.

Inside Health Insurance Exchanges provides hard-hitting news and strategies on the details of state and private health insurance exchanges, for business planners with health plans, hospitals and health systems, medical groups, ancillary providers, suppliers, pharma companies and state health policy makers. This 12-page monthly newsletter answers questions about this cornerstone of the health reform law — who will participate, what product designs will look like, the effect on enrollment, and more. Subscribers receive reliable intelligence on how to make the most of the enormous transformation in health insurance that is about to unfold … and succeed in the insurance marketplace of tomorrow.

Inside Health Insurance Exchanges is written by an experienced team of health business reporters – led by Managing Editor Steve Davis and Executive Editor Jill Brown – with extensive knowledge and contacts throughout the health insurance industry. AIS has been the industry’s #1 health care business publisher for 25 years, with Health Plan Week, AIS’s Health Reform Week and Medicare Advantage News among its dozens of highly regarded titles for health business leaders.

For more information on Inside Health Insurance Exchanges, including the February Issue and subscription information, visit http://aishealth.com/marketplace/inside-health-insurance-exchanges.

###

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Portsmouth, VA (Vocus/PRWEB) March 22, 2011

Chock full o’Nuts, “The Heavenly Coffee™,” and the Parkinson’s Disease Foundation (PDF) today kicked off a campaign designed to generate awareness about Parkinson’s disease and the need to fund research for new treatments and a cure.

Dennis Crawford, senior marketing manager for Massimo Zanetti Beverage USA and the Chock full o’Nuts brand, and Robin Elliott, Executive Director of the Parkinson’s Disease Foundation, announced a multi-faceted promotional effort that would continue throughout the year.

“Parkinson’s is a disease that affects nearly one million Americans,” Crawford said. “Massimo Zanetti Beverage USA and the Chock full o’Nuts brand are pleased to partner with the Parkinson’s Disease Foundation in this campaign that will encourage people to join the fight against Parkinson’s by raising awareness of this debilitating disease and supporting PDF’s research programs.”

According to Crawford, Chock full o’Nuts cafes and coffee shops from New York City to Sicily’s Sigonella Air Force Base will feature in-store promotional counter signage and specially identified cups tied to the PDF cause. Retail consumers and online orders will soon see one million specially marked cans of Chock with messaging from the Parkinson’s Disease Foundation. A full-page coupon insert will appear March 27th in 35 million Sunday newspapers across the country. Finally, to drive online traffic to the PDF website, a special link from chockfullonuts.com will connect visitors to PDF information and encourage clicks for donations.

New York’s famous Chock full o’Nuts coffee brand has a longtime association with the Parkinson’s Disease Foundation. William Black, the originator of Chock full o’Nuts coffee, began the Parkinson’s Disease Foundation in 1957 when he learned that his lifelong friend and business associate had developed the disease. Today, William Black’s wife and well-known singer of the Chock heavenly coffee jingle, Page Morton Black, serves as PDF’s board chairman.

Robin Elliott said of the partnership, “The Parkinson’s Disease Foundation has been committed to finding the cause(s) of and a cure for Parkinson’s disease for over 54 years. We are certain that Mr. Black would be happy to know that the two organizations he founded are now partnering to push forward progress toward these goals and we thank Chock full o’Nuts for its support.”

About the Brand—Chock full o’Nuts. William Black opened his first nut shop on Broadway and 43rd Street in 1926, and six years later, his first coffee shop in 1932. The Great Depression caused Black to convert his chain of 18 nut shops into coffee shops which sold a good cup of coffee and a sandwich for a nickel. In 1953, Black began selling his own brand of coffee – named after his small coffee shops — in local supermarkets; his “Chock full o’Nuts” brand coffee was an immediate success with New York grocery shoppers. The company’s radio and TV jingle, “Chock full o’Nuts is that heavenly coffee, better coffee a millionaire’s money can’t buy” are known, loved (and hummed) by heart by generations of New Yorkers. Visit us online at: http://www.chockfullonuts.com

About Massimo Zanetti Beverage USA

Massimo Zanetti Beverage USA is among the nation’s largest coffee roasters, with nationally recognized retail brands including Chock full o’Nuts®, Hills Bros.®, Segafredo Zanetti®, MJB®, and Chase & Sanborn®. With its headquarters and state-of-the art manufacturing facility located in southeastern Virginia, the company produces proprietary and private label coffee, tea and drink mix for customers in all retail and food service channels throughout North America and around the world. In addition, Massimo Zanetti Beverage USA franchises Chock full o’Nuts® Coffee Shops and Segafredo Zanetti Espresso® Cafés. http://www.mzb-usa.com

About the Parkinson’s Disease Foundation

The Parkinson’s Disease Foundation ® (PDF®) is a leading national presence in Parkinson’s disease research, education and public advocacy. PDF is working for the nearly one million people in the US who live with Parkinson’s by funding promising scientific research while supporting people living with Parkinson’s through educational programs and services. Since its founding in 1957, PDF has dedicated over $ 85 million to fund the work of leading scientists throughout the world and over $ 34 million to support national education and advocacy initiatives.

About Parkinson’s Disease

Parkinson’s disease (PD) is a progressive neurological disorder that affects nearly one million people in the US and seven to 10 million people worldwide. Although promising research is being conducted, there is currently no cure for Parkinson’s. For more information, visit the Parkinson’s Disease Foundation: http://www.pdf.org

###

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

(PRWEB) February 18, 2012

The Institute for Preparing Heirs™ (IPH) will hold its hallmark professional development program, “The Great Wealth Transfer: Attracting & Retaining MultiGenerational Families of Wealth”, March 11-13, at Pepperdine University in Malibu, Ca. Developed exclusively for family wealth advisors, this only program of its kind is led by a world-class faculty of highly acclaimed authors, distinguished researchers and educators, and leading experts on family dynamics and wealth transition planning.

“We are experiencing the largest intergenerational wealth transfer in history,” said Vic Preisser, co-founder of IPH and co-author of Preparing Heirs, Five Steps to a Successful Transition of Family Wealth and Values. “More than $ 1 trillion in wealth is transferring to the next generation each year in the U.S.; however, over 90% of heirs promptly change advisors upon receiving their inheritance. Most families lose control of their assets and harmony in the first generation after wealth transfer regardless of how well their advisors have prepared the assets.”

IPH’s groundbreaking “The Great Wealth Transfer” professional development program sets a new standard of learning for family wealth advisors who want to ensure the longevity of their businesses by strengthening relationships with the multi-generations of current and prospective client families. Advisors who would benefit by attending include:

    Financial advisors
    Estate planning attorneys
    CPA’s
    Family office executives
    Insurance executives
    Family business consultants
    Other family wealth advisors who work with successful families and individuals

Participants will leave the program with a solid understanding of:

    A clear process that addresses the impact of family dynamics on wealth transition in affluent families—a present-day gap in traditional wealth management
    Helpful new resources, including IPH’s Guide to Family Wealth Conversations. This tool was created for use by families to foster conversations to help open channels of communication, strengthen trust, prepare family members for the responsibilities of wealth, explore family financial literacy and more.
    A new research-based Family Self-Assessment tool that accurately measures a family’s current readiness for wealth transfer across several key areas

The program format provides advisors with small group forums to share new ideas, discuss new strategies, and develop an action plan tailored specifically for their businesses.

Headquartered in Pasadena, CA, IPH teaches family wealth advisors how to start the conversation with families of wealth about the successful transfer of wealth to their next generation and provides resources and tools to support the relationship.

In addition to Vic Preisser, the faculty includes Drs. Robert Kenny and Karen Weisgerber with Boston College Center for Wealth and Philanthropy; Gary Shunk, family coach and founder of Family Wealth Dynamics; and Mark Percy, family philanthropy coach and founder of Next Generation Strategies.

Advisors may enroll by contacting IPH at (626) 389-8664 or online at preparingheirs.com. Cost to attend is $ 3,000 and includes a one-year IPH membership with full access to IPH’s tools, resources, discounted books and speakers, family wealth newsletter, discussion forums and more. Special payment plans are available.

###

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Los Angeles, CA (PRWEB) February 15, 2012

Dr. Zeid Kayali, MD, MBA, leading hepatologist in Los Angeles, is a member of the elite Haute Living Haute MD Network. An exclusive invitation-only group, the doctors representing the network are at the pinnacle of their industries. Dr. Kayali was handpicked for his exceptional skill in hepatology. His practice is concentrated on liver transplantation and hepatology. Haute Living Magazine will feature Dr. Kayali as an exclusive Haute MD.

Read more about him here. http://www.hautemd.com/doctors/dr-zeid-kayali-md-mba/

About Haute MD Network

The exclusive Haute Living Haute MD Network is made up of the most prestigious doctors across the US. Doctors are revered and invited for their skill in one of nine specialties: Breast, Face, Smile, Nose, Skin, Body, Bones, Hair, and Lasik. The Haute MD blog is frequently updated with groundbreaking news, trends and events in the industry, and is the ultimate source for finding the best doctor in your area. Visit http://www.hautemd.com today.

About Dr. Zeid Kayali

Dr. Kayali attended Aleppo University in Syria, where he received his MD degree. He is currently a transplant hepatologist at the University of Southern California. He is also American Board-certified in Internal Medicine, Gastroenterology and Hepatology, and Liver Transplantation.

Dr. Kayali’s main research interests include hepatocellular carcinoma and hepatitis C. He is currently conducting multiple research trials in treating hepatitis C and liver cancer.

# # #

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Vienna, VA (PRWEB) June 30, 2006

Origo Biosciences, a life sciences company, announced today that it has identified a dietary antibody to cholesterol. When ingested, this naturally-occurring protein binds to cholesterol in the human digestive tract and blocks its absorption into the bloodstream.

The discovery of this dairy-derived cholesterol absorption inhibitor may enable a new generation of functional dairy ingredients. Whey protein concentrates with anti-cholesterol antibodies would provide food and beverage companies with yet another proven functional food ingredient that already has widespread consumer appeal.

Elevated cholesterol levels are considered to be the single most important predictor of atherosclerosis and coronary heart disease. More than $ 33 billion is spent on pharmaceutical products and another $ 3 billion on functional foods that help consumers to manage their cholesterol levels.

Managing cholesterol at the site of absorption is an increasingly popular strategy in the war on hypercholesterolemia. Phytosterols are currently the only cholesterol absorption inhibitor approved for use as a food ingredient. And Zetia™, the new blockbuster drug from Schering-Plough and Merck, is the only such inhibitor approved as a drug.

Origo evaluated dairy sources from the US, Europe, New Zealand and Australia, including whey protein concentrates, colostrums, and fluid milks, measuring levels of anti-cholesterol antibodies. The company found a wide variation in anti-cholesterol concentrations, with several sources containing many hundreds of times more activity than the most popular whey protein concentrates and fluid milks.

The company recently completed an in vitro evaluation of several sources, measuring their impact on cholesterol absorption in human intestinal cells. Origo found that several of these sources significantly blocked cholesterol uptake at levels exceeding those previously reported for phytosterols and Zetia™.

Anti-cholesterol antibodies were discovered nearly a half a century ago. Numerous studies have since shown that when these antibodies are introduced into circulation they facilitate the clearance of harmful forms of cholesterol such as LDL and VLDL. Origo’s current discovery and intellectual property recognizes that these antibodies may also be found in certain dairy sources and may be effective in the digestive tract, preventing the absorption of cholesterol.

Origo is currently collaborating with a major research university to evaluate the efficacy in a preclinical animal trial. Following the completion of these preclinical studies, the company plans to conduct a human clinical evaluation.

About Origo Biosciences

Origo Biosciences is a life sciences company focused on the discovery of dairy-derived oral immunotherapeutics for the treatment of chronic disease and gastrointestinal disorders.

The company’s lead product is Anticholesterol™, a dairy derived, orally-active antibody that binds to cholesterol. This antibody is believed to block the absorption of cholesterol from the digestive tract into the bloodstream.

Targeting cholesterol at the site of absorption is an increasingly popular strategy in the $ 36 billion dollar battle against hypercholesterolemia, atherosclerosis, and coronary heart disease.

For more information, visit http://www.origobiosciences.com.

# # #

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Morristown, New Jersey (PRWEB) February 16, 2012

Trajectory (http://www.trajectory4brands.com), a leading NJ-based branding and marketing firm working across well-being, beauty and healthcare industries, announced today its partnership with full-service interactive firm Matchpoint Digital (http://www.matchpointdigital.com), with offices in NY, NC and Buenos Aires.

The partnership creates a seamless front-end to back-end resource for well-being, beauty and healthcare marketers to create more meaningful and measurable engagement through strategically-driven, cost-effective interactive solutions including: websites, micro-sites and promotional sites, portals, mobile and tablet apps, rich media, social media, eCRM, custom CMS platforms and advergames.

Trajectory has carved out a strong niche across these growing categories,” said Michael Piatt, President of Matchpoint Digital. “In the short time we’ve been working together, Trajectory has impressed us with its vision, expertise and energy. They are well positioned to play a larger role in influencing their client’s brand relationships and business growth, and our collaboration will enhance this opportunity.”

Adds Eric Brody, Trajectory President, “this relationship is a win-win for our respective companies and our well-being, beauty and healthcare clients. We complement each other very well, and our partnership will help our clients’ marketing teams to achieve more meaningful and measurable levels of engagement through growing digital, mobile and social channels.”

About Trajectory

Trajectory is an industry-recognized branding and marketing firm working across well-being, beauty and healthcare industries. Through its “Brand Energy” approach, the firm works with clients to energize their organizations, create new value and deliver new growth. Representative clients include Palomar (PaloVia™ skin renewing laser), Orlando Health, Arnold Palmer Enterprises, The Reading Hospital and Medical Center and AUI Gourmet Foods. Learn more about Trajectory by contacting Eric Brody, President at 973-292-1400 x201 or email him at eb(at)trajectory4brands(dot)com.

About Matchpoint Digital

Matchpoint Digital is a full-service interactive development firm. Our philosopy is simple. Do what we do well (which is development), leave the strategy and creative up to our clients, and deliver a results-driven, cost-effective digital solution. Representative clients include Novo Nordisk, Gerber and Nestle. Learn more about Matchpoint Digital by contacting Michael Piatt, President at 212-495-9159 or email him at michael(at)matchpointdigital(dot)com.

###

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Pure Energy

(PRWEB) February 14, 2012

True Healthy Products, a Florida fitness and nutrition company is now offering a free bottle of their all natural “Pure Energy” pre workout formula with the purchase of their muscle recovery booster, “The Daily Optimizer”.

The offer is available on their website: http://www.truehealthyproducts.com/products/sports-nutrition/nitraplex

The company formulated “Pure Energy” so it could be used alone or as an accompaniment to their all natural “Daily Optimizer” muscle recovery booster. For a limited time, with the purchase of the Daily Optimizer, the Pure Energy supplement will be available free to give customers an opportunity to take the two supplements together and experience the maximum results when the products are used together.

From the company’s website, http://www.truehealthyproducts.com, benefits of the two supplements are highlighted:

Pure Energy will help support:        

Increased energy    
Increased mental focus
Increased endurance

Daily Optimizer will help support:

Increased overall performance and well being
Enhancing the body’s ability to repair & build muscle
Relieving joint and muscle aches

According to the formulator, Andrew Wood, “These products are designed to compliment each other to produce maximum results. It is always recommended to have a clean healthy diet and exercise routine to achieve your personal desired results.”

“Daily Optimizer and Pure Energy helps me regulate hormones, helps me sleep and helps me with my recovery, I have increases energy, mental focus there are no jitters and no crash. They are all natural, no additives or sugars; it is the only safe alternative to energy.” – Rod Johnston, Fire Department Training Chief

True Healthy Products is an all natural health and wellness company that is dedicated to high standards in quality of products and customer service. For more information about supplements or other natural products offered by the company like wholefood vitamins, homeopathic diets, and natural dark chocolate, visit the company’s website at http://www.truehealthyproducts.com.

True Healthy Products

2460 N. Courtenay Parkway, #210

Merritt Island, FL 32953

888-400-2920

###

Attachments

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.